The effect of HBF2019-02 on lipid metabolism - The effect of HBF2019-02 on lipid metabolism

Oneness Support Co., Ltd0 个研究点目标入组 22 人开始时间: 2019年9月16日最近更新: 2023年10月17日

试验速览

暂无简介。

•(1) Subjects with hepatic, renal, cardiac and/or organ disorders, diabetes, and/or other serious diseases. (2) Subjects with abnormal liver and kidney function test values. (3) Subjects with a disease currently being treated. (4) Subjects with food and drug allergies. (5) Subjects with anemia. (6) Subjects who play intense sports and subjects who are on a diet. (7) Subjects who cannot refrain from taking health foods (including certain health foods and functionally labeled foods) and designated quasi drugs during the test period. (8) Those who continue to take medicines (including OTC and prescription drugs). (9) Those who consume excessive alcohol, or who cannot ban alcohol from the day before the test to the day. (10) Participants in or planning to participate in other clinical studies at the start of this study. (11) Subjects who judged as unsuitable for this study by the principal investigator for any reasons.

发起方

Oneness Support Co., Ltd